{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:27:09Z","timestamp":1766766429719,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 NS065705"],"award-info":[{"award-number":["U54 NS065705"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.trsl.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T14:20:24Z","timestamp":1619101224000},"page":"129-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells"],"prefix":"10.1016","volume":"235","author":[{"given":"Qiuwang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Cannavicci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie E.","family":"Faughnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.B.","family":"Kutryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2021.04.005_bib0001","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199510053331407","article-title":"Hereditary hemorrhagic telangiectasia","volume":"333","author":"Guttmacher","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.04.005_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2015.00001","article-title":"Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era","volume":"6","author":"McDonald","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2006.041517","article-title":"SMAD4 mutations found in unselected HHT patients","volume":"43","author":"Gallione","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0006","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.2006.042606","article-title":"Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations","volume":"43","author":"Prigoda","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0007","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","article-title":"BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia","volume":"93","author":"Wooderchak-Donahue","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0008","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1038\/hgv.2015.40","article-title":"Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia","volume":"2","author":"Hernandez","year":"2015","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.trsl.2021.04.005_bib0009","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tcb.2017.04.005","article-title":"Transforming growth factor-\u03b2 receptors and Smads: regulatory complexity and functional versatility","volume":"27","author":"Budi","year":"2017","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0011","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7150\/ijbs.8.195","article-title":"TGF\u03b2 signaling and cardiovascular diseases","volume":"8","author":"Pardali","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.trsl.2021.04.005_bib0012","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/01.ATV.0000225287.20034.2c","article-title":"Transforming growth factor-betas and vascular disorders","volume":"26","author":"Bobik","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0013","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","article-title":"Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK5 signaling","volume":"12","author":"Goumans","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2021.04.005_bib0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardiores.2004.10.036","article-title":"Ten Dijke P. TGF-beta receptor function in the endothelium","volume":"65","author":"Lebrin","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcp.20311","article-title":"Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex","volume":"204","author":"Blanco","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0016","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","article-title":"Endoglin promotes endothelial cell proliferation and TGF-beta\/ALK1 signal transduction","volume":"23","author":"Lebrin","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.trsl.2021.04.005_bib0017","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.284.5419.1534","article-title":"Defective angiogenesis in mice lacking endoglin","volume":"284","author":"Li","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.trsl.2021.04.005_bib0018","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI8088","article-title":"A murine model of hereditary hemorrhagic telangiectasia","volume":"104","author":"Bourdeau","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2021.04.005_bib0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/dbio.1999.9534","article-title":"Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development","volume":"217","author":"Arthur","year":"2000","journal-title":"Dev Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1083\/jcb.2094fta","article-title":"VEGF tips its hand in angiogenesis","volume":"209","author":"Short","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0021","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0022","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ncb2103","article-title":"Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting","volume":"12","author":"Jakobsson","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","article-title":"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice","volume":"376","author":"Shalaby","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2021.04.005_bib0024","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2021.04.005_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/376070a0","article-title":"Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation","volume":"376","author":"Sato","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2021.04.005_bib0026","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.tips.2016.10.003","article-title":"Therapeutics targeting FGF signaling network in human diseases","volume":"37","author":"Katoh","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2021.04.005_bib0027","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.04.005_bib0028","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.6199844","article-title":"Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor","volume":"223","author":"Shing","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.trsl.2021.04.005_bib0029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cvr\/cvm086","article-title":"Non-canonical fibroblast growth factor signalling in angiogenesis","volume":"78","author":"Murakami","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08977190500096004","article-title":"Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells","volume":"23","author":"Antoine","year":"2005","journal-title":"Growth Factors"},{"key":"10.1016\/j.trsl.2021.04.005_bib0031","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/labinvest.3700597","article-title":"Selective control of endothelial cell proliferation with a synthetic dimerizer of FGF receptor-1","volume":"87","author":"Nourse","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2021.04.005_bib0032","doi-asserted-by":"crossref","first-page":"33679","DOI":"10.1074\/jbc.M004994200","article-title":"Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor","volume":"275","author":"Lee","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.04.005_bib0033","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/(SICI)1097-0177(199812)213:4<421::AID-AJA7>3.0.CO;2-B","article-title":"Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development","volume":"213","author":"Leconte","year":"1998","journal-title":"Dev Dyn"},{"key":"10.1016\/j.trsl.2021.04.005_bib0034","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/excr.1998.4359","article-title":"VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK\/ERK and SAPK\/JNK signaling","volume":"247","author":"Gupta","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0035","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","article-title":"Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation","volume":"273","author":"Gerber","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.04.005_bib0036","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1139\/cjpp-2018-0424","article-title":"Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension","volume":"97","author":"Zhang","year":"2019","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0037","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1074\/jbc.273.29.18514","article-title":"Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2","volume":"273","author":"Witzenbichler","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.04.005_bib0038","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/sj.onc.1203800","article-title":"Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway","volume":"19","author":"Kim","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2021.04.005_bib0039","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1096\/fj.201700867RR","article-title":"Endoglin interacts with VEGFR2 to promote angiogenesis","volume":"32","author":"Tian","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2021.04.005_bib0040","doi-asserted-by":"crossref","first-page":"e86273","DOI":"10.1371\/journal.pone.0086273","article-title":"ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2021.04.005_bib0041","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ncb3534","article-title":"Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signaling","volume":"19","author":"Jin","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signaling-in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0043","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/ATVBAHA.118.310760","article-title":"ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation","volume":"38","author":"Alsina-Sanch\u00eds","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0044","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/cells8090971","article-title":"PI3K (phosphatidylinositol 3-kinase) activation and endothelial cell proliferation in patients with hemorrhagic hereditary telangiectasia type 1","volume":"8","author":"Iriarte","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2021.04.005_bib0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1074\/jbc.M112.417451","article-title":"Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells","volume":"288","author":"Mazor","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2021.04.005_bib0046","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1161\/01.RES.86.12.e110","article-title":"Nuclear factor-kappaB and cAMP response element binding protein mediate opposite transcriptional effects on the Flk-1\/KDR gene promoter","volume":"86","author":"Illi","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0047","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-5793(02)03879-6","article-title":"Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding","volume":"535","author":"Urbich","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.trsl.2021.04.005_bib0048","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1158\/0008-5472.CAN-08-3150","article-title":"Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells","volume":"69","author":"Meissner","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0049","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/jcp.24596","article-title":"ERK3 promotes endothelial cell functions by upregulating SRC-3\/SP1-mediated VEGFR2 expression","volume":"229","author":"Wang","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0050","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1093\/emboj\/cdf688","article-title":"Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression","volume":"21","author":"Tzima","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.trsl.2021.04.005_bib0051","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1600-0625.2009.00867.x","article-title":"Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells","volume":"18","author":"Meissner","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2021.04.005_bib0052","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/01.RES.0000113781.08139.81","article-title":"PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation","volume":"94","author":"Meissner","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0053","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cdd.2009.152","article-title":"VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2","volume":"17","author":"Zhang","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.trsl.2021.04.005_bib0054","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2337\/diabetes.52.12.2959","article-title":"Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells","volume":"52","author":"Cai","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2021.04.005_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cardiores.2005.06.009","article-title":"Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions","volume":"68","author":"Fernandez-L","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2021.04.005_bib0056","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1096\/fj.14-269258","article-title":"Increased endothelial cell permeability in endoglin-deficient cells","volume":"29","author":"Jerkic","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2021.04.005_bib0057","first-page":"1392","article-title":"Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-\u03b2 signaling pathways","volume":"126","author":"Park","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2021.04.005_bib0058","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10456-018-9602-0","article-title":"Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia","volume":"21","author":"Crist","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.trsl.2021.04.005_bib0059","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2362.2007.01824.x","article-title":"Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia","volume":"37","author":"Thomas","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2021.04.005_bib0060","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMc0901421","article-title":"Bevacizumab in hereditary hemorrhagic telangiectasia","volume":"360","author":"Bose","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.04.005_bib0061","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMc091271","article-title":"More on bevacizumab in hereditary hemorrhagic telangiectasia","volume":"361","author":"Oosting","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2021.04.005_bib0062","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2021.04.005_bib0063","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2017.11.013","article-title":"Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding","volume":"93","author":"Iyer","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trsl.2021.04.005_bib0064","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/joim.12832","article-title":"Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia","volume":"285","author":"Al-Samkari","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.trsl.2021.04.005_bib0065","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/hmg\/ddu531","article-title":"Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function","volume":"24","author":"Mallet","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2021.04.005_bib0066","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.109.211037","article-title":"Pathogenesis of arteriovenous malformations in the absence of endoglin","volume":"106","author":"Mahmoud","year":"2010","journal-title":"Circ Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:44:56Z","timestamp":1761828296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524421000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":66,"alternative-id":["S1931524421000876"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2021.04.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"type":"print","value":"1931-5244"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}